Avista Capital Partners III GP L.P. 13D and 13G filings for RVL Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-09 5:20 pm Purchase |
2022-08-08 | 13D | RVL Pharmaceuticals plc RVLPQ |
Avista Capital Partners III GP L.P. | 23,730,864 24.000% |
8,000,000 (+50.86%) |
Filing |
| 2021-10-14 4:10 pm Unchanged |
2021-10-12 | 13D | RVL Pharmaceuticals plc RVLPQ |
Avista Capital Partners III GP L.P. | 15,730,864 18.900% |
0 (Unchanged) |
Filing |
| 2020-11-23 4:53 pm Unchanged |
2020-11-20 | 13D | RVL Pharmaceuticals plc RVLPQ |
Avista Capital Partners III GP L.P. | 15,730,864 25.200% |
0 (Unchanged) |
Filing |